摘要
目的:研究7种化疗方案致初治卵巢癌和乳腺癌患者贫血发生情况。方法:回顾性分析2008年5月～2009年2月在北京大学人民医院初治的卵巢癌和乳腺癌患者110例的病历资料,调查不同化疗方案患者治疗前、后血红蛋白水平,应用SPSS软件分析数据。结果:在110例患者中,发生Ⅰ级贫血194例/次,Ⅱ级贫血55例/次。以铂类制剂为基础的化疗方案贫血发生率高,TA方案贫血发生率低,年龄越大越易贫血。结论:化疗后贫血的发生与癌症类型、化疗方案、化疗周期、患者年龄均有关系。
OBJECTIVE：To study the situation of anemia in newly diagnosed ovarian cancer and breast cancer patients treated with 7 kinds of chemotherapy regimes. METHODS：110 cases of newly diagnosed ovarian cancer and breast cancer from May 2008 to Feb. 2009 in People’s Hospital of Peking University were analyzed retrospectively. The level of hemoglobin in patients treated with different chemotherapy regimes were evaluated and analyzed with SPSS software. RESULTS：Of total 110 patients, class Ⅰ anemia occurred 194 times and class Ⅱ anemia occurred 55 times. High incidence of anemia appeared in chemotherapy regimes with platinum as base. Low incidence of anemia occurred in TA chemotherapy regime. The older patient is,the more easily anemia occurred. CONCLUSION：The incidence of anemia after chemotherapy is related to type of cancer,chemotherapy regime, chemotherapy cycle and patient’s age.
出处
《中国药房》
CAS
CSCD
北大核心
2010年第14期1305-1307,共3页
China Pharmacy
关键词
乳腺癌
卵巢癌
化疗
贫血
Breast cancer
Ovarian cancer
Chemotherapy
Anemia
